Celltrion Pharm Inc.

Celltrion Pharm, Inc., a KOSDAQ-listed Korean biopharma subsidiary, focuses on biosimilars and OTC drugs across hepatology, immunology, oncology and more, serving hospitals and retail pharmacies, with a pipeline of innovative generics and high growth potential.

Headquarters: South Korea (KOR)

Celltrion Pharm Inc. Logo
Company Profile
  • HQ: Cheongju-si
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
068760 Celltrion Pharm Inc.
Cap: 2812.7B
EQUITY KOE KRW KR7068760008 Active
📈
Home Login